Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 408
interventional 264
Observational 127
Registry 17

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 126
Device 38
Other 23
Drug|placebo 22
Procedure 14
Behavioral 10
Drug|Other 6
Device|Other 3
Diagnostic Test 3
Behavioral|Device 2
Device|Drug 2
Behavioral|Combination Product 1
Behavioral|Genetic 1
Behavioral|Other 1
Biological 1
Biological|Device 1
Biological|Other 1
Combination Product|Drug 1
Combination Product|Drug|placebo 1
Device|placebo 1
Device|Procedure 1
Diagnostic Test|Drug 1
Drug|Other|placebo 1
Drug|Procedure 1
Genetic 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 75
Canada 17
France 15
NA 15
China 10
Italy 10
Japan 9
Netherlands 5
United Kingdom 5
Brazil 4
Ireland 4
Sweden 4
United States|Canada 4
Denmark 3
Egypt 3
Korea, Republic of 3
Norway 3
Russian Federation 3
Canada|France|Switzerland 2
Germany 2
Israel 2
Switzerland 2
Taiwan 2
NA 1
Australia|Austria|Brazil|Germany|Hungary|Israel|Italy|Netherlands|South Africa 1
Australia|Canada 1
Belgium 1
Belgium|Canada|Czech Republic|France|Germany|Hungary|Italy|Netherlands|Poland|Russian Federation|Slovenia 1
Belgium|United States|Australia|Austria|Brazil|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Puerto Rico|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
Brazil|United States|Argentina|Australia|Austria|Belgium|Canada|Chile|Colombia|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Bulgaria|Croatia|Czechia|France|Germany|Poland|Romania|Serbia|Spain 1
Bulgaria|Czech Republic|Estonia|France|Germany|Greece|Hungary|Israel|Italy|Latvia|Netherlands|Poland|Russian Federation|Slovakia|Spain|Switzerland|Ukraine 1
Bulgaria|Germany|Ireland|United Kingdom 1
Canada|Israel|Netherlands|Norway|Sweden 1
Canada|Italy 1
Canada|Netherlands 1
Canada|New Zealand 1
Canada|United States|Australia|Austria|Belgium|Brazil|Czech Republic|Denmark|Finland|France|Germany|Italy|Netherlands|New Zealand|Norway|Poland|South Africa|Spain|Sweden|United Kingdom 1
Colombia 1
Colombia|Austria|Belgium|Brazil|Chile|China|Czech Republic|Denmark|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Ukraine|United Kingdom 1
Czech Republic|Australia|Austria|Belgium|Brazil|Canada|Colombia|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Peru|Poland|South Africa|Spain|Sweden|Switzerland 1
Finland 1
Georgia|Russian Federation 1
Germany|France|Italy|Netherlands|Russian Federation|Spain 1
Hong Kong 1
India 1
Iran, Islamic Republic of 1
Iraq 1
Italy|Netherlands 1
Japan|Taiwan 1
Netherlands|United States|Belgium|Canada|France|Ireland|Norway|Russian Federation|Spain 1
Nigeria 1
Poland|United States|Australia|Austria|Czech Republic|France|Israel|Italy|Netherlands|South Africa|Sweden 1
Saudi Arabia 1
Singapore 1
Slovenia 1
Spain 1
Tunisia 1
Turkey 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Egypt|Estonia|France|Greece|India|Israel|Italy|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Portugal|Puerto Rico|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|France|Israel|Italy|Mexico|Netherlands|New Zealand|Poland|Russian Federation|South Africa|Spain|Turkey 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|China|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Czech Republic|Denmark|France|Germany|Hong Kong|India|Israel|Italy|Korea, Republic of|Mexico|Norway|Philippines|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|China|Denmark|France|Germany|Hungary|India|Israel|Mexico|Norway|Poland|Romania|Russian Federation|Spain|Sweden|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Denmark|Hungary|Israel|Mexico|Poland|Russian Federation|Sweden|Turkey 1
United States|Argentina|Australia|Canada|Denmark|Israel|Mexico|Poland|Puerto Rico 1
United States|Argentina|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|El Salvador|France|Germany|Guatemala|Hungary|India|Israel|Kenya|Korea, Republic of|Lebanon|Malaysia|Netherlands|Norway|Panama|Portugal|Russian Federation|Serbia|Singapore|Slovenia|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Denmark|France|Germany|Hong Kong|India|Ireland|Italy|Malaysia|Netherlands|New Zealand|Pakistan|Poland|Russian Federation|Saudi Arabia|South Africa|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Austria|Brazil|Canada|Hungary|Israel|Italy|Japan|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|France|Germany|Ireland|Israel|Italy|Switzerland 1
United States|Australia|Austria|Canada|France|Germany|Israel|Italy|Netherlands|Switzerland 1
United States|Australia|Austria|Canada|Israel|Netherlands 1
United States|Australia|Brazil|Canada|Czech Republic|Denmark|France|Israel|Italy|Netherlands|Poland|South Africa|Sweden 1
United States|Australia|Brazil|Canada|India|Israel|Latvia|Lithuania|Poland|Russian Federation|South Africa|Ukraine|United Kingdom 1
United States|Australia|Brazil|Canada|Saudi Arabia|United Kingdom 1
United States|Australia|Canada|Chile|Colombia|Czech Republic|Denmark|France|Italy|Poland|Portugal|Russian Federation|Slovakia|South Africa|Spain|United Kingdom 1
United States|Austria|Belgium|Germany|Italy|Netherlands|Switzerland 1
United States|Belgium|Chile 1
United States|Belgium|France|Hungary|Italy|Netherlands 1
United States|Canada|France|India|Italy|Jordan|Lebanon|Spain|Turkey|United Kingdom 1
United States|Canada|Ireland|United Kingdom 1
United States|France|Germany|Italy|Sweden|United Kingdom 1

Sites per Study

Site_count Study_Count
1 149
2 16
3 6
4 2
5 3
6 3
7 3
8 2
9 6
11 4
12 3
13 3
14 3
15 2
16 2
18 4
20 3
21 1
22 2
23 2
24 2
25 2
28 1
29 2
30 2
33 1
34 1
35 1
36 1
37 1
38 2
56 1
57 1
59 1
63 1
65 1
67 1
70 1
73 1
78 1
95 1
101 1
107 1
110 1
122 2
134 1
139 1
143 1
148 1
151 1
170 1
227 1
267 1
297 1
322 1
324 1
382 1
429 1
454 1

Phase

Phase Study_Count
N/A 106
Phase 3 66
Phase 4 41
Phase 2 26
Phase 1 12
Early Phase 1 6
Phase 2/Phase 3 6
Phase 1/Phase 2 1

Number of Arms

Number_of_Arms Count_of_Studies
1 56
2 144
3 15
4 12
5 3
8 1
10 1
NA 32

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0 5.0000 8.00000 50 21.0000 11 14.000 13.0000
1st Qu. 20.0 36.2500 34.50000 50 65.5000 30 113.500 97.0000
Median 35.0 140.0000 49.50000 50 193.5000 56 561.000 251.0000
Mean 69.0 694.6604 55.08333 50 306.4231 291 1358.094 985.6585
3rd Qu. 99.5 417.7500 82.50000 50 518.0000 120 1249.000 600.0000
Max. 198.0 19652.0000 118.00000 50 1225.0000 1238 10000.000 20000.0000

Trial Group Type

group_type Group_Count
Experimental 229
Active Comparator 158
NA 32
No Intervention 31
Other 27
Placebo Comparator 24
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 168
Single Group Assignment 71
Crossover Assignment 14
Factorial Assignment 5
NA 4
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 118
Prevention 88
Diagnostic 24
Other 10
Basic Science 9
Health Services Research 4
Screening 4
Supportive Care 3
NA 3
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 23
NA 13
France 12
Canada 7
Italy 7
Germany 6
United Kingdom 5
Belgium 3
Czechia 3
Israel 3
Netherlands 3
Spain 3
Brazil 2
China 2
Denmark 2
France|Switzerland 2
Mexico 2
Norway 2
Sweden 2
Switzerland 2
Algeria|Egypt|Indonesia|Jordan|Kazakhstan|Kenya|Korea, Republic of|Kuwait|Lebanon|Malaysia|Mexico|Morocco|Philippines|Qatar|Russian Federation|Saudi Arabia|Singapore|Taiwan|Turkey|Ukraine|United Arab Emirates 1
Argentina 1
Australia 1
Australia|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Moldova, Republic of|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1
Austria|France|Germany|Ireland 1
Benin|Burkina Faso|Burundi|Cameroon|Congo, The Democratic Republic of the|Congo|Côte D’Ivoire|Gabon|Guinea|Mozambique|Niger|Senegal|Sudan 1
Canada|Netherlands|Switzerland 1
Canada|Norway|Sweden 1
Finland 1
France|Italy|Mexico|Netherlands 1
Greece 1
India 1
Netherlands|Switzerland 1
Puerto Rico 1
Russian Federation 1
Taiwan 1
United States|Belgium|France|Italy|Spain 1
United States|Canada 1
United States|Canada|France|Italy|Spain 1
United States|Canada|Germany|Italy|Slovakia 1
United States|Canada|Netherlands|Switzerland 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 89
2 10
3 4
4 1
5 5
7 1
8 2
9 2
10 2
12 1
15 1
18 1
20 2
21 2
25 1
26 1
36 2

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 100.00
Median 350.00
Mean 19609.42
3rd Qu 1000.00
Max 665533.00

Observation Model

observational_model Study_Count
Cohort 95
Case-Only 15
NA 6
Case-Control 4
Other 4
Case Control 3

Time Perspective

time_perspective Study_Count
Prospective 95
Retrospective 23
Cross-Sectional 4
Other 3
Cross-Sectional, Prospective 1
NA 1

Registries

Studies by Country

Country Study_Count
United States 6
Italy 2
Australia 1
Austria 1
Austria|Germany|Italy 1
Brazil 1
France 1
Germany 1
NA 1
Russian Federation 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 14
2 1
4 1
13 1

Enrollment Metrics

Measure Registries
Min 5
1st Qu 196
Median 400
Mean 7191
3rd Qu 800
Max 100000

Registry Model

observational_model Study_Count
Cohort 14
Other 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 16
Cross-Sectional 1

Follow-up

target_duration Study_Count
12 Months 3
2 Years 3
1 Month 2
1 Day 1
1 Year 1
12 Weeks 1
14 Days 1
3 Days 1
3 Months 1
3 Years 1
5 Days 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04462003 Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04462003 Recruiting Beni-Suef University 2020-07-02
NCT03368313 Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT03368313 Recruiting Pró Circulação® 2020-11-30
NCT03339349 Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma https://ClinicalTrials.gov/show/NCT03339349 Completed University of Utah 2019-06-30
NCT03328624 A Preliminary Clinical Usability Study for the Recovery Force DVT II Cuff https://ClinicalTrials.gov/show/NCT03328624 Completed University of Southern California 2018-03-06
NCT03327688 Point-of-care Ultrasound in Finland https://ClinicalTrials.gov/show/NCT03327688 Recruiting Kuopio University Hospital 2019-07-31
NCT03317145 Lower Limb Blood Flow Geko vs Foot Pump https://ClinicalTrials.gov/show/NCT03317145 Completed Hampshire Hospitals NHS Foundation Trust 2014-02-19
NCT03250247 Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) https://ClinicalTrials.gov/show/NCT03250247 Recruiting Washington University School of Medicine 2021-12-31
NCT03240120 A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03240120 Recruiting The University of Hong Kong 2021-05-31
NCT03212365 Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery https://ClinicalTrials.gov/show/NCT03212365 Completed University of Utah 2019-06-02
NCT03201367 Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV https://ClinicalTrials.gov/show/NCT03201367 Completed Zagazig University 2016-08-01
NCT03195777 Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT https://ClinicalTrials.gov/show/NCT03195777 Recruiting Massachusetts General Hospital 2022-03-31
NCT03193502 Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT03193502 Recruiting Tanta University 2020-07-31
NCT03129555 The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) https://ClinicalTrials.gov/show/NCT03129555 Recruiting Danish Heart Foundation 2020-03-31
NCT03075761 Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT) https://ClinicalTrials.gov/show/NCT03075761 Completed University of Texas Southwestern Medical Center 2019-10-09
NCT03068338 Robotic Sock Technology for Prevention of Deep Vein Thrombosis and Joint Contracture https://ClinicalTrials.gov/show/NCT03068338 Completed National University Hospital, Singapore 2017-12-06
NCT03251963 Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients https://ClinicalTrials.gov/show/NCT03251963 Completed University of Utah 2019-03-27
NCT03050671 Effects of External Leg Compression Devices on Healing and Blood Clotting https://ClinicalTrials.gov/show/NCT03050671 Enrolling by invitation Karolinska University Hospital 2020-03-01
NCT03044574 Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03044574 Completed Pirogov Russian National Research Medical University 2018-09-30
NCT03038893 Point of Care Ultrasound For The Diagnosis Of Deep Venous Thrombosis And Its Effect On Length Of Hospital Stay https://ClinicalTrials.gov/show/NCT03038893 Completed Hospital de Clinicas de Porto Alegre 2016-11-30
NCT02978950 SToP: Venous Thromboembolism Screening in the Trauma Population https://ClinicalTrials.gov/show/NCT02978950 Recruiting Intermountain Health Care, Inc. 2019-12-31
NCT02970032 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin https://ClinicalTrials.gov/show/NCT02970032 Completed University of Utah 2017-09-10
NCT02945280 Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT02945280 Recruiting Intermountain Health Care, Inc. 2023-12-31
NCT02920125 Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT. https://ClinicalTrials.gov/show/NCT02920125 Completed Health Solutions, India 2017-08-31
NCT02892565 Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System) https://ClinicalTrials.gov/show/NCT02892565 Completed Central Hospital, Nancy, France 2009-12-31
NCT02889562 Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02889562 Completed Sanford Health 2019-05-11
NCT02859532 Study of Elastographic Properties of the Clot by Technical SWIRE (Shear Wave Induced Resonance Elastography) https://ClinicalTrials.gov/show/NCT02859532 Recruiting University Hospital, Grenoble 2019-02-28
NCT02810704 Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement https://ClinicalTrials.gov/show/NCT02810704 Active, not recruiting Dartmouth-Hitchcock Medical Center 2022-08-31
NCT02803398 Modelling Interface Pressure Applied by Superimposed Compression Bandages https://ClinicalTrials.gov/show/NCT02803398 Completed Thuasne 2016-12-31
NCT02744092 Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer https://ClinicalTrials.gov/show/NCT02744092 Active, not recruiting Alliance Foundation Trials, LLC. 2020-06-30
NCT02722447 Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT02722447 Recruiting Università degli Studi dell’Insubria 2019-06-30
NCT02704598 Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs. https://ClinicalTrials.gov/show/NCT02704598 Recruiting Hospital do Servidor Publico Estadual 2018-12-31
NCT02704052 Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose https://ClinicalTrials.gov/show/NCT02704052 Completed University of Utah 2018-07-31
NCT02687204 Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients https://ClinicalTrials.gov/show/NCT02687204 Completed University of Utah 2017-06-23
NCT02600260 Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial https://ClinicalTrials.gov/show/NCT02600260 Active, not recruiting University of Sao Paulo General Hospital 2019-07-31
NCT02585713 Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02585713 Completed Academic and Community Cancer Research United 2018-04-02
NCT02581176 Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study https://ClinicalTrials.gov/show/NCT02581176 Completed University Hospital, Akershus 2018-05-31
NCT03080883 Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy https://ClinicalTrials.gov/show/NCT03080883 Recruiting Academic and Community Cancer Research United 2022-05-01
NCT02567903 Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System https://ClinicalTrials.gov/show/NCT02567903 Completed Groene Hart Ziekenhuis 2019-06-30
NCT02555111 Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. https://ClinicalTrials.gov/show/NCT02555111 Completed Assistance Publique - Hôpitaux de Paris 2020-02-29
NCT02537457 Bioequivalence Study of Rivaroxaban https://ClinicalTrials.gov/show/NCT02537457 Completed Bayer 2014-03-31
NCT02537405 Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects https://ClinicalTrials.gov/show/NCT02537405 Completed Bayer 2014-03-31
NCT02486445 Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study https://ClinicalTrials.gov/show/NCT02486445 Completed Ostfold Hospital Trust 2018-11-30
NCT02485184 TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis https://ClinicalTrials.gov/show/NCT02485184 Recruiting Fourth Military Medical University 2021-12-31
NCT02411292 Enoxaparin Metabolism in Reconstructive Surgery Patients https://ClinicalTrials.gov/show/NCT02411292 Completed University of Utah 2016-03-31
NCT02402881 Education Bundle to Decrease Patient Refusal of VTE Prophylaxis https://ClinicalTrials.gov/show/NCT02402881 Completed Johns Hopkins University 2018-11-30
NCT02384135 Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study https://ClinicalTrials.gov/show/NCT02384135 Recruiting University Hospital, Geneva 2019-08-31
NCT02379663 Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT02379663 Completed Samsung Medical Center 2013-01-31
NCT02376803 The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The “INRange” RCT https://ClinicalTrials.gov/show/NCT02376803 Completed University of Alberta 2016-09-30
NCT02368314 A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries https://ClinicalTrials.gov/show/NCT02368314 Completed Biocad 2015-12-31
NCT02342444 Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) https://ClinicalTrials.gov/show/NCT02342444 Recruiting Oregon Health and Science University 2020-12-31
NCT02318472 Early Mobilization After Achilles Tendon Rupture https://ClinicalTrials.gov/show/NCT02318472 Active, not recruiting Karolinska University Hospital 2018-03-31
NCT02309411 EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis https://ClinicalTrials.gov/show/NCT02309411 Completed Bayer 2017-04-05
NCT02303431 Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study https://ClinicalTrials.gov/show/NCT02303431 Recruiting Daiichi Sankyo, Inc. 2020-09-30
NCT02301793 Educating Nurses About Venous Thromboembolism (VTE) Prevention https://ClinicalTrials.gov/show/NCT02301793 Completed Johns Hopkins University 2015-03-31
NCT02265523 Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02265523 Completed Lakehead University 2018-02-01
NCT02262052 Advanced Diagnostic Management of Suspected Recurrent Ipsilateral DVT With MRDTI https://ClinicalTrials.gov/show/NCT02262052 Completed Leiden University Medical Center 2019-03-31
NCT02250391 Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis https://ClinicalTrials.gov/show/NCT02250391 Completed Nihon Pharmaceutical Co., Ltd 2016-03-31
NCT02247414 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection https://ClinicalTrials.gov/show/NCT02247414 Completed Yangzhou University 2017-09-30
NCT02238444 Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy https://ClinicalTrials.gov/show/NCT02238444 Recruiting Yangzhou University 2019-09-30
NCT02211326 Genotype-guided Warfarin Individualized Treatment https://ClinicalTrials.gov/show/NCT02211326 Completed The Third Xiangya Hospital of Central South University 2017-01-16
NCT02205294 Osteopathic Treatment and Deep Vein Thrombosis (DVT) https://ClinicalTrials.gov/show/NCT02205294 Active, not recruiting Nova Scotia Health Authority 2020-06-30
NCT02186223 The Angel® Catheter Pivotal Clinical Trial https://ClinicalTrials.gov/show/NCT02186223 Completed BiO2 Medical 2015-12-31
NCT02161965 Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation https://ClinicalTrials.gov/show/NCT02161965 Completed University Hospital, Angers 2016-12-31
NCT02159521 Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System https://ClinicalTrials.gov/show/NCT02159521 Completed EKOS Corporation 2017-11-30
NCT02148757 Doppler Ultrasound Following Unicondylar Knee Replacement to Determine the Incidence of Postoperative DVT https://ClinicalTrials.gov/show/NCT02148757 Completed Hospital for Special Surgery, New York 2015-08-31
NCT02148029 Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome https://ClinicalTrials.gov/show/NCT02148029 Active, not recruiting VA Office of Research and Development 2021-08-31
NCT02123524 Rivaroxaban Anticoagulation for Superficial Vein Thrombosis https://ClinicalTrials.gov/show/NCT02123524 Completed McMaster University 2018-12-03
NCT02102828 Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT02102828 Completed TriHealth Inc. 2015-03-31
NCT02073682 Cancer Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02073682 Completed Daiichi Sankyo, Inc. 2017-09-15
NCT02070237 Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis https://ClinicalTrials.gov/show/NCT02070237 Completed MemorialCare Health System 2014-03-31
NCT02065388 Pharmacogenetic Dosing of Warfarin https://ClinicalTrials.gov/show/NCT02065388 Completed Academia Sinica, Taiwan 2013-12-31
NCT02064439 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) https://ClinicalTrials.gov/show/NCT02064439 Completed Bayer 2016-09-22
NCT01317160 Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture https://ClinicalTrials.gov/show/NCT01317160 Completed Karolinska University Hospital 2015-08-31
NCT01285661 Optimal Duration of Anticoagulation in Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT01285661 Completed University of Padova 2015-10-31
NCT02040103 Pneumatic Compression for Preventing Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02040103 Completed King Abdullah International Medical Research Center 2018-11-13
NCT02015364 Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization https://ClinicalTrials.gov/show/NCT02015364 Completed Hvidovre University Hospital 2018-02-28
NCT01999179 Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis https://ClinicalTrials.gov/show/NCT01999179 Active, not recruiting Medical College of Wisconsin 2020-12-31
NCT01979328 Gekoâ„¢ Plaster Cast Study, Deep Vein Thrombosis (DVT) Prophylaxis https://ClinicalTrials.gov/show/NCT01979328 Completed University Hospital Southampton NHS Foundation Trust 2012-05-31
NCT01976637 Compression Treatment of Superficial Vein Thrombosis https://ClinicalTrials.gov/show/NCT01976637 Completed Medical University of Vienna 2013-11-30
NCT01975090 The SENTRY Clinical Study https://ClinicalTrials.gov/show/NCT01975090 Completed Novate Medical 2016-08-31
NCT01935414 Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study https://ClinicalTrials.gov/show/NCT01935414 Active, not recruiting Firstkind Ltd 2016-11-16
NCT01894997 A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower Limb https://ClinicalTrials.gov/show/NCT01894997 Completed National University of Ireland, Galway, Ireland 2014-04-30
NCT01886612 A Comparison of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Terms of Lower Limb Blood Flow https://ClinicalTrials.gov/show/NCT01886612 Completed National University of Ireland, Galway, Ireland 2013-08-31
NCT01880216 Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT https://ClinicalTrials.gov/show/NCT01880216 Completed Berlin-Chemie AG Menarini Group 2015-01-31
NCT01862471 Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow https://ClinicalTrials.gov/show/NCT01862471 Completed National University of Ireland, Galway, Ireland 2013-06-30
NCT01828697 Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy https://ClinicalTrials.gov/show/NCT01828697 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-12-31
NCT01796015 Intracranial Hypertension and Optic Nerve Sheath Diameter https://ClinicalTrials.gov/show/NCT01796015 Completed Hospices Civils de Lyon 2017-02-28
NCT01785251 Neuromuscular Electrical Stimulation Following Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT01785251 Completed National University of Ireland, Galway, Ireland 2012-02-29
NCT01780987 AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients https://ClinicalTrials.gov/show/NCT01780987 Completed Pfizer 2014-09-30
NCT01779648 Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT01779648 Completed Seoul National University Hospital 2013-01-31
NCT01729559 Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin https://ClinicalTrials.gov/show/NCT01729559 Completed Scripps Health 2014-09-30
NCT01684423 Oral Rivaroxaban in Children With Venous Thrombosis https://ClinicalTrials.gov/show/NCT01684423 Completed Bayer 2016-09-01
NCT01662908 A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis https://ClinicalTrials.gov/show/NCT01662908 Completed Daiichi Sankyo, Inc. 2014-01-31
NCT01630148 Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries https://ClinicalTrials.gov/show/NCT01630148 Completed Hawler Medical University 2014-03-31
NCT01613794 Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis https://ClinicalTrials.gov/show/NCT01613794 Completed Leiden University Medical Center 2016-12-31
NCT01608906 Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery https://ClinicalTrials.gov/show/NCT01608906 Completed University of Colorado, Denver 2014-05-31
NCT01578122 Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome https://ClinicalTrials.gov/show/NCT01578122 Completed Laboratoires Innothera 2019-06-28
NCT01573169 PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients https://ClinicalTrials.gov/show/NCT01573169 Recruiting University Of Perugia 2020-12-31
NCT01556282 TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis https://ClinicalTrials.gov/show/NCT01556282 Completed Emory University 2014-01-31
NCT01542762 Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation https://ClinicalTrials.gov/show/NCT01542762 Completed Leiden University Medical Center 2016-07-31
NCT01542723 Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy https://ClinicalTrials.gov/show/NCT01542723 Completed Leiden University Medical Center 2016-07-31
NCT01524653 Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) https://ClinicalTrials.gov/show/NCT01524653 Completed University of Vermont 2016-07-01
NCT01516840 Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients https://ClinicalTrials.gov/show/NCT01516840 Completed Bayer 2013-12-31
NCT01507051 Switching Study From Warfarin to Rivaroxaban https://ClinicalTrials.gov/show/NCT01507051 Completed Bayer 2009-11-30
NCT01499953 Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux https://ClinicalTrials.gov/show/NCT01499953 Completed GWT-TUD GmbH 2016-06-30
NCT01495429 Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care https://ClinicalTrials.gov/show/NCT01495429 Completed University of Michigan 2015-07-31
NCT01482273 Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT01482273 Completed University Hospital Inselspital, Berne 2013-11-30
NCT01446887 Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT01446887 Completed The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2010-12-31
NCT01429714 The Ideal Deep Venous Thrombosis (DVT) Study https://ClinicalTrials.gov/show/NCT01429714 Completed Maastricht University Medical Center 2017-07-01
NCT01412242 Simplification of the Diagnosis of Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT01412242 Completed University of Padova 2014-07-31
NCT01403090 Safety Study of the Angelâ„¢ Catheter in Subjects With Risk of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01403090 Completed BiO2 Medical 2012-03-31
NCT04256525 Prophylactic Anticoagulation for Catheter-related Thrombosis https://ClinicalTrials.gov/show/NCT04256525 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2021-08-30
NCT01354704 Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin https://ClinicalTrials.gov/show/NCT01354704 Completed Les Laboratoires des Médicaments Stériles 2015-07-31
NCT01347203 A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting https://ClinicalTrials.gov/show/NCT01347203 Completed Diakron Pharmaceuticals 2011-06-30
NCT01333618 Introducer Curving Technique for Tilt of Transfemoral Günther Tulip Inferior Vena Cava Filter https://ClinicalTrials.gov/show/NCT01333618 Completed China Medical University, China 2010-06-30
NCT01326949 Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis https://ClinicalTrials.gov/show/NCT01326949 Completed Fourth Military Medical University 2016-01-31
NCT01319474 Whole-leg Ultrasound in Pregnant Patients https://ClinicalTrials.gov/show/NCT01319474 Recruiting Intermountain Health Care, Inc. 2020-07-31
NCT04411316 Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04411316 Recruiting University of Toledo Health Science Campus 2022-12-19
NCT04393909 Improving Safety of Diagnosis and Therapy in the Inpatient Setting https://ClinicalTrials.gov/show/NCT04393909 Recruiting Brigham and Women’s Hospital 2021-06-30
NCT04367831 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04367831 Recruiting Columbia University 2020-11-30
NCT04341272 Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis https://ClinicalTrials.gov/show/NCT04341272 Completed Baltimore VA Medical Center 2017-04-05
NCT04294849 Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04294849 Recruiting University of Texas Southwestern Medical Center 2022-12-31
NCT04169269 Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban https://ClinicalTrials.gov/show/NCT04169269 Recruiting Florida Orthopaedic Institute 2020-12-31
NCT04156230 Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT04156230 Recruiting Asan Medical Center 2020-08-30
NCT04136561 Novel Strategy to Encourage Early Removal of Central Venous Catheters https://ClinicalTrials.gov/show/NCT04136561 Recruiting William Beaumont Hospitals 2021-06-30
NCT04128956 Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS https://ClinicalTrials.gov/show/NCT04128956 Recruiting University of Zurich 2022-08-31
NCT04022915 PET Fibrin Imaging of DVT and PE https://ClinicalTrials.gov/show/NCT04022915 Recruiting Massachusetts General Hospital 2023-05-13
NCT03999905 Impact of Pharmacists’ Training on Oral Anticoagulant Counseling https://ClinicalTrials.gov/show/NCT03999905 Completed University of Ibadan 2019-09-30
NCT03987321 Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter https://ClinicalTrials.gov/show/NCT03987321 Recruiting Yonsei University 2020-05-31
NCT03945045 A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD https://ClinicalTrials.gov/show/NCT03945045 Recruiting National Taiwan University Hospital 2024-01-31
NCT03911661 Fearon Algorithm in Warfarin Patient Self-Management https://ClinicalTrials.gov/show/NCT03911661 Recruiting University of Utah 2020-04-30
NCT03908866 Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit https://ClinicalTrials.gov/show/NCT03908866 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2019-12-31
NCT03895502 Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study https://ClinicalTrials.gov/show/NCT03895502 Recruiting Kyoto University, Graduate School of Medicine 2022-04-01
NCT03868956 Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs https://ClinicalTrials.gov/show/NCT03868956 Recruiting Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 2023-01-17
NCT03812848 Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program https://ClinicalTrials.gov/show/NCT03812848 Active, not recruiting Ain Shams University 2019-06-30
NCT03804697 Selective Thromboembolism Prophylaxis After Arthroplasty https://ClinicalTrials.gov/show/NCT03804697 Completed Guangdong Provincial People’s Hospital 2017-08-31
NCT03757481 Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE https://ClinicalTrials.gov/show/NCT03757481 Recruiting University Hospital, Montpellier 2020-10-17
NCT03747081 Efficacy Comparison of Warfarin Versus Rivaroxaban CVT https://ClinicalTrials.gov/show/NCT03747081 Recruiting Isfahan University of Medical Sciences 2020-01-01
NCT03740633 Functional Training for the Prevention of Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT03740633 Recruiting Peking Union Medical College Hospital 2019-11-10
NCT03682419 Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) https://ClinicalTrials.gov/show/NCT03682419 Completed LumiraDx UK Limited 2018-11-23
NCT03634124 Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs https://ClinicalTrials.gov/show/NCT03634124 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-03-31
NCT03573492 Bedside Ultrasound in the Assessment of Deep Venous Thrombosis: Effectiveness of In-Person Versus Online Instruction https://ClinicalTrials.gov/show/NCT03573492 Completed Mercy Health Ohio 2018-12-05
NCT03516656 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin https://ClinicalTrials.gov/show/NCT03516656 Active, not recruiting University of Utah 2019-06-30
NCT03506815 Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines https://ClinicalTrials.gov/show/NCT03506815 Recruiting Ottawa Hospital Research Institute 2019-12-30
NCT03505723 PeriOperative ISchemic Evaluation-3 Trial https://ClinicalTrials.gov/show/NCT03505723 Recruiting Population Health Research Institute 2021-02-28
NCT03489135 The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation https://ClinicalTrials.gov/show/NCT03489135 Active, not recruiting Vetex Medical Ltd. 2021-04-30
NCT03443310 Bedside Ultrasound by Anesthesiologists for Screening Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT03443310 Completed University Health Network, Toronto 2014-12-31
NCT03428711 Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis https://ClinicalTrials.gov/show/NCT03428711 Recruiting Quovadis Associazione 2022-03-31
NCT03420664 Comparison of the Effects of Lower Limb Immobilisation With Cast and Orthosis https://ClinicalTrials.gov/show/NCT03420664 Recruiting Karolinska University Hospital 2020-12-24
NCT03420625 Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices https://ClinicalTrials.gov/show/NCT03420625 Completed Karolinska University Hospital 2017-01-31
NCT03413618 Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT03413618 Completed Pirogov Russian National Research Medical University 2019-07-31
NCT01245998 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis https://ClinicalTrials.gov/show/NCT01245998 Completed University Medical Centre Ljubljana 2012-12-03
NCT01240330 Vasculaire Compression System Increases Flow Velocity in the Femoral Vein https://ClinicalTrials.gov/show/NCT01240330 Completed Venous Health Systems, Inc. 2010-09-30
NCT01203098 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT01203098 Completed Daiichi Sankyo, Inc. 2008-12-31
NCT01203072 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01203072 Completed Daiichi Sankyo, Inc. 2007-09-30
NCT01145859 Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects https://ClinicalTrials.gov/show/NCT01145859 Completed Bayer 2015-07-31
NCT01104337 Drug Interaction Between Paracetamol and Warfarin https://ClinicalTrials.gov/show/NCT01104337 Completed Hopital Lariboisière 2008-11-30
NCT00986154 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). https://ClinicalTrials.gov/show/NCT00986154 Completed Daiichi Sankyo, Inc. 2013-04-30
NCT00967148 Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer https://ClinicalTrials.gov/show/NCT00967148 Completed Ottawa Hospital Research Institute 2010-09-30
NCT00911157 The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients https://ClinicalTrials.gov/show/NCT00911157 Completed GlaxoSmithKline 2009-11-30
NCT00910364 Feasibility Study of Exercise in Patients With Leg Blood Clots https://ClinicalTrials.gov/show/NCT00910364 Completed University of Oklahoma 2012-12-31
NCT00904982 Randomized Trial of Interventions to Improve Warfarin Adherence https://ClinicalTrials.gov/show/NCT00904982 Completed University of Pennsylvania 2012-05-31
NCT00904293 Genotype-Guided Warfarin Therapy Trial https://ClinicalTrials.gov/show/NCT00904293 Completed University of North Carolina, Chapel Hill 2012-01-31
NCT00894283 Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients https://ClinicalTrials.gov/show/NCT00894283 Completed Johns Hopkins University 2013-09-30
NCT00878826 Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. https://ClinicalTrials.gov/show/NCT00878826 Completed Stanford University 2011-08-31
NCT00858130 Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS) https://ClinicalTrials.gov/show/NCT00858130 Completed University of North Carolina, Chapel Hill 2009-11-30
NCT00853463 Discharge ALERT: Quality Improvement Initiative https://ClinicalTrials.gov/show/NCT00853463 Completed Brigham and Women’s Hospital 2010-03-31
NCT00843492 A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery https://ClinicalTrials.gov/show/NCT00843492 Completed GlaxoSmithKline 2010-01-31
NCT00839657 Clarification of Optimal Anticoagulation Through Genetics https://ClinicalTrials.gov/show/NCT00839657 Completed National Heart, Lung, and Blood Institute (NHLBI) 2013-04-30
NCT00839163 Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) https://ClinicalTrials.gov/show/NCT00839163 Completed Bayer 2005-10-31
NCT03367364 Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis https://ClinicalTrials.gov/show/NCT03367364 Active, not recruiting Johns Hopkins University 2020-12-01
NCT02598609 SEPREVEN: a Stepped-wedge Randomised Controlled Trial https://ClinicalTrials.gov/show/NCT02598609 Active, not recruiting Centre Hospitalier Intercommunal Creteil 2020-03-30
NCT01981733 Improving Lower Limb Blood Flow in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT01981733 Completed Queen Mary University of London 2012-04-30
NCT01324037 Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT01324037 Completed University Medical Center Groningen 2013-03-31
NCT03178864 Study of Rivaroxaban for CeREbral Venous Thrombosis https://ClinicalTrials.gov/show/NCT03178864 Recruiting University of British Columbia 2020-12-31
NCT02798471 Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02798471 Recruiting Daiichi Sankyo, Inc. 2020-12-31
NCT02627053 Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study https://ClinicalTrials.gov/show/NCT02627053 Recruiting Università degli Studi dell’Insubria 2019-06-30
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707 Recruiting Central Hospital, Nancy, France 2020-09-30
NCT00812370 The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids https://ClinicalTrials.gov/show/NCT00812370 Completed Children’s Hospital Los Angeles 2013-01-31
NCT00790335 Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis https://ClinicalTrials.gov/show/NCT00790335 Completed Washington University School of Medicine 2017-01-31
NCT00786422 Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer https://ClinicalTrials.gov/show/NCT00786422 Completed Bayer 2011-05-31
NCT00773448 Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00773448 Completed Ottawa Hospital Research Institute 2015-04-30
NCT00740493 Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) https://ClinicalTrials.gov/show/NCT00740493 Completed University Hospital, Brest 2017-01-31
NCT00728819 Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters https://ClinicalTrials.gov/show/NCT00728819 Completed University of Pennsylvania 2011-01-31
NCT00720915 D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months https://ClinicalTrials.gov/show/NCT00720915 Completed McMaster University 2016-12-31
NCT00689520 Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT00689520 Completed Hospital Universitari de Bellvitge 2005-01-31
NCT00687882 Evaluation of the Duration of Therapy for Thrombosis in Children https://ClinicalTrials.gov/show/NCT00687882 Active, not recruiting Johns Hopkins All Children’s Hospital 2020-12-31
NCT00643201 Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00643201 Completed Bristol-Myers Squibb 2013-03-31
NCT00633893 Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00633893 Completed Bristol-Myers Squibb 2012-08-31
NCT00628576 Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities https://ClinicalTrials.gov/show/NCT00628576 Completed Aalborg University Hospital 2004-06-30
NCT00623987 Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants https://ClinicalTrials.gov/show/NCT00623987 Completed Azienda Ospedaliera Universitaria Policlinico 2006-06-30
NCT00622102 Testing Strategies to Improving Warfarin Adherence https://ClinicalTrials.gov/show/NCT00622102 Completed University of Pennsylvania 2009-04-30
NCT00621491 Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation https://ClinicalTrials.gov/show/NCT00621491 Completed University of Sao Paulo 2007-09-30
NCT01300832 The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities https://ClinicalTrials.gov/show/NCT01300832 Recruiting University of Chicago 2023-12-31
NCT00603317 Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid https://ClinicalTrials.gov/show/NCT00603317 Completed Assistance Publique - Hôpitaux de Paris 2010-03-31
NCT00585182 Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT https://ClinicalTrials.gov/show/NCT00585182 Completed University of Utah 2008-04-30
NCT00554632 Birth Control Pill vs Birth Control Patch Study https://ClinicalTrials.gov/show/NCT00554632 Completed University of Vermont NA
NCT00511173 Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm https://ClinicalTrials.gov/show/NCT00511173 Completed Creighton University 2008-11-30
NCT00457158 PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption https://ClinicalTrials.gov/show/NCT00457158 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-11-30
NCT00457002 Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness https://ClinicalTrials.gov/show/NCT00457002 Completed Bristol-Myers Squibb 2011-05-31
NCT00452530 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00452530 Completed Bristol-Myers Squibb 2009-01-31
NCT00443053 Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) https://ClinicalTrials.gov/show/NCT00443053 Completed GlaxoSmithKline 2009-07-31
NCT00440193 Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study https://ClinicalTrials.gov/show/NCT00440193 Completed Bayer 2010-04-30
NCT00439725 Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study https://ClinicalTrials.gov/show/NCT00439725 Completed Bayer 2009-08-31
NCT00438230 Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants https://ClinicalTrials.gov/show/NCT00438230 Completed Azienda Ospedaliera Universitaria Policlinico NA
NCT00436787 Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers https://ClinicalTrials.gov/show/NCT00436787 Completed University of Pittsburgh NA
NCT00426075 Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic Syndrome https://ClinicalTrials.gov/show/NCT00426075 Completed University of Padova 2007-11-30
NCT00423319 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) https://ClinicalTrials.gov/show/NCT00423319 Completed Bristol-Myers Squibb 2009-09-30
NCT00421538 Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT) https://ClinicalTrials.gov/show/NCT00421538 Completed University Hospital, Geneva 2015-05-31
NCT00401414 Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information https://ClinicalTrials.gov/show/NCT00401414 Completed Brigham and Women’s Hospital 2011-06-30
NCT00413504 Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00413504 Completed Brigham and Women’s Hospital NA
NCT00413374 Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00413374 Completed Brigham and Women’s Hospital 2008-04-30
NCT00395772 Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis https://ClinicalTrials.gov/show/NCT00395772 Completed Bayer NA
NCT00380120 Ultrasound Findings to Adjust the Duration of Anticoagulation https://ClinicalTrials.gov/show/NCT00380120 Completed University of Padova 2003-06-30
NCT00371683 Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00371683 Completed Bristol-Myers Squibb 2008-05-31
NCT00365950 3 Months’ Versus 6 Months’ Anticoagulation in Patients With DVT and/or PE https://ClinicalTrials.gov/show/NCT00365950 Completed British Thoracic Society NA
NCT00362947 Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis https://ClinicalTrials.gov/show/NCT00362947 Completed St. Orsola Hospital 2010-09-30
NCT00358735 Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) https://ClinicalTrials.gov/show/NCT00358735 Completed Medical Compression Systems 2008-09-30
NCT00356759 Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients https://ClinicalTrials.gov/show/NCT00356759 Completed McMaster University 2010-01-31
NCT00353093 The ERASMUS Study: Limited vs Extended US for DVT Diagnosis https://ClinicalTrials.gov/show/NCT00353093 Completed University of Padova NA
NCT00351663 The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients https://ClinicalTrials.gov/show/NCT00351663 Completed Shaare Zedek Medical Center 2014-04-30
NCT00346424 Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters https://ClinicalTrials.gov/show/NCT00346424 Completed ARCA Biopharma, Inc. 2006-10-31
NCT00345618 Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach https://ClinicalTrials.gov/show/NCT00345618 Completed Sanofi 2010-10-31
NCT00334464 A Pharmacogenetic Study of Warfarin Dosing, “The COUMA-GEN Study” https://ClinicalTrials.gov/show/NCT00334464 Completed Intermountain Health Care, Inc. NA
NCT00333697 Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients https://ClinicalTrials.gov/show/NCT00333697 Completed Intermountain Health Care, Inc. 2011-01-31
NCT00329433 Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery https://ClinicalTrials.gov/show/NCT00329433 Completed Washington University School of Medicine 2008-10-31
NCT00322270 Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters https://ClinicalTrials.gov/show/NCT00322270 Completed ARCA Biopharma, Inc. NA
NCT00320398 Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) https://ClinicalTrials.gov/show/NCT00320398 Completed GlaxoSmithKline 2006-07-18
NCT00314990 VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis https://ClinicalTrials.gov/show/NCT00314990 Completed Radboud University NA
NCT00312013 Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer https://ClinicalTrials.gov/show/NCT00312013 Completed GlaxoSmithKline 2009-07-31
NCT00311090 Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs https://ClinicalTrials.gov/show/NCT00311090 Completed Sanofi 2008-01-31
NCT00306254 Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery https://ClinicalTrials.gov/show/NCT00306254 Completed Pfizer NA
NCT00277394 Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT00277394 Completed LEO Pharma 2008-05-31
NCT00265993 Enoxaparin in Acute Venous Thromboembolic Disease https://ClinicalTrials.gov/show/NCT00265993 Completed Sanofi 2009-01-31
NCT00264277 D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00264277 Completed St. Orsola Hospital 2004-12-31
NCT00252005 Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study https://ClinicalTrials.gov/show/NCT00252005 Completed Bristol-Myers Squibb 2007-02-28
NCT00251771 Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis https://ClinicalTrials.gov/show/NCT00251771 Completed Oslo University Hospital 2014-12-31
NCT00246025 A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. https://ClinicalTrials.gov/show/NCT00246025 Completed Boehringer Ingelheim 2007-06-30
NCT00245856 Treatment of Upper Extremity Deep-Vein Thrombosis https://ClinicalTrials.gov/show/NCT00245856 Completed University of Oklahoma 2009-03-31
NCT00244725 Odiparcil For The Prevention Of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00244725 Completed GlaxoSmithKline 2006-09-30
NCT00244270 Cystic Fibrosis and Totally Implantable Vascular Access Devices https://ClinicalTrials.gov/show/NCT00244270 Completed Assistance Publique - Hôpitaux de Paris 2009-03-31
NCT00225108 The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section https://ClinicalTrials.gov/show/NCT00225108 Completed Ottawa Hospital Research Institute NA
NCT00216866 The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT00216866 Completed Lawson Health Research Institute 2006-03-31
NCT00211146 A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) https://ClinicalTrials.gov/show/NCT00211146 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00203658 Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin https://ClinicalTrials.gov/show/NCT00203658 Completed University of Calgary NA
NCT00203580 Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) https://ClinicalTrials.gov/show/NCT00203580 Completed University of Calgary NA
NCT00187408 The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial https://ClinicalTrials.gov/show/NCT00187408 Completed Sunnybrook Health Sciences Centre NA
NCT00185952 Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor. https://ClinicalTrials.gov/show/NCT00185952 Completed Stanford University 2007-01-31
NCT00182403 Fixed Dose Heparin Study https://ClinicalTrials.gov/show/NCT00182403 Completed McMaster University NA
NCT00182364 PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) https://ClinicalTrials.gov/show/NCT00182364 Completed McMaster University NA
NCT00182351 D-Dimer Vs Serial Compression Ultrasound Study https://ClinicalTrials.gov/show/NCT00182351 Completed McMaster University NA
NCT00170378 The Use of Low Molecular Weight Heparin in Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT00170378 Completed Hennepin Healthcare Research Institute NA
NCT00162435 Genetic Determinants of Warfarin Anticoagulation Effect https://ClinicalTrials.gov/show/NCT00162435 Recruiting Hadassah Medical Organization 2020-12-31
NCT00157677 Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT) https://ClinicalTrials.gov/show/NCT00157677 Completed McMaster University 2010-06-30
NCT00157599 MDA D-Dimer / Recurrent DVT Study https://ClinicalTrials.gov/show/NCT00157599 Completed McMaster University NA
NCT00143598 The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome https://ClinicalTrials.gov/show/NCT00143598 Completed Sir Mortimer B. Davis - Jewish General Hospital 2012-02-29
NCT00123734 Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT00123734 Completed Agen Biomedical NA
NCT00114608 Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot https://ClinicalTrials.gov/show/NCT00114608 Completed University at Buffalo 2007-07-31
NCT00097357 BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00097357 Completed Bristol-Myers Squibb 2005-12-31
NCT00082355 Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins https://ClinicalTrials.gov/show/NCT00082355 Completed National Institutes of Health Clinical Center (CC) 2010-03-31
NCT00071279 SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT00071279 Completed Sanofi 2005-12-31
NCT00067093 Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) https://ClinicalTrials.gov/show/NCT00067093 Completed Sanofi 2005-09-30
NCT00056550 Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. https://ClinicalTrials.gov/show/NCT00056550 Completed rEVO Biologics 2004-02-29
NCT00182143 PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) https://ClinicalTrials.gov/show/NCT00182143 Completed McMaster University 2010-06-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03050138 Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran https://ClinicalTrials.gov/show/NCT03050138 Completed Oslo University Hospital 2019-01-31
NCT04349189 Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait https://ClinicalTrials.gov/show/NCT04349189 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-15
NCT03340623 Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ? https://ClinicalTrials.gov/show/NCT03340623 Completed Brugmann University Hospital 2018-05-28
NCT03296280 Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program https://ClinicalTrials.gov/show/NCT03296280 Enrolling by invitation VA Office of Research and Development 2018-06-29
NCT03286985 The Prevalence and Incidence of DVT in General ICU https://ClinicalTrials.gov/show/NCT03286985 Completed Masaryk Hospital Krajská zdravotní a.s. 2017-12-31
NCT03271450 The DARE Warfarin CER Study https://ClinicalTrials.gov/show/NCT03271450 Enrolling by invitation Brigham and Women’s Hospital 2021-04-15
NCT03231449 A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa https://ClinicalTrials.gov/show/NCT03231449 Active, not recruiting Cardiologie et Développement 2020-12-31
NCT03141749 Venous Thromboembolism in DM1 https://ClinicalTrials.gov/show/NCT03141749 Completed Institut de Myologie, France 2014-11-30
NCT03124654 Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC) https://ClinicalTrials.gov/show/NCT03124654 Completed University Hospital, Basel, Switzerland 2017-07-30
NCT03116750 Post-Market Clinical Follow-up Study With ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT https://ClinicalTrials.gov/show/NCT03116750 Recruiting Straub Medical AG 2021-12-30
NCT03100071 Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients https://ClinicalTrials.gov/show/NCT03100071 Recruiting Lawson Health Research Institute 2019-12-30
NCT03036540 Upper Limb Thrombosis Associated With Midline Catheter https://ClinicalTrials.gov/show/NCT03036540 Recruiting University Hospital, Motol 2019-12-31
NCT03033966 Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous Thrombosis https://ClinicalTrials.gov/show/NCT03033966 Completed National Institute of Mental Health and Neuro Sciences, India 2016-06-30
NCT03031717 Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS https://ClinicalTrials.gov/show/NCT03031717 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2022-04-30
NCT03015025 Pharmacogenetic Dosage Algorithm for Acenocoumarol https://ClinicalTrials.gov/show/NCT03015025 Completed Instituto de Investigación Hospital Universitario La Paz 2013-10-31
NCT02884934 Six Years of Follow-up After Idiopathic Venous Throbmoembolism https://ClinicalTrials.gov/show/NCT02884934 Recruiting University Hospital, Brest 2022-11-30
NCT02867163 Tranexamic Acid and Blood Clots in Knee Surgery https://ClinicalTrials.gov/show/NCT02867163 Completed University of New Mexico 2017-11-08
NCT02809638 A New Technique to Diagnose Acute and Chronic Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT02809638 Completed Azienda Sanitaria Locale ASL 6, Livorno 2017-06-21
NCT02742623 A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer https://ClinicalTrials.gov/show/NCT02742623 Completed Bayer 2018-11-30
NCT02719418 Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses https://ClinicalTrials.gov/show/NCT02719418 Completed Maisonneuve-Rosemont Hospital 2016-09-30
NCT02699151 INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis https://ClinicalTrials.gov/show/NCT02699151 Active, not recruiting GWT-TUD GmbH 2019-08-30
NCT02651909 Utilization of TEG to Monitor Rivaroxaban Activity https://ClinicalTrials.gov/show/NCT02651909 Completed University of Pittsburgh 2018-07-07
NCT02650453 Ongoing Registry of Deep Venous Reconstructions https://ClinicalTrials.gov/show/NCT02650453 Recruiting Maastricht University Medical Center 2019-09-30
NCT02597218 Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. https://ClinicalTrials.gov/show/NCT02597218 Recruiting Hospital Italiano de Buenos Aires 2019-10-31
NCT02584842 Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy https://ClinicalTrials.gov/show/NCT02584842 Completed University Hospital, Basel, Switzerland 2014-12-31
NCT02552420 The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02552420 Completed The First Affiliated Hospital of Guangzhou Medical University 2012-07-31
NCT02523937 Evaluation of Soluble Fibrin in Thrombosis Exclusion https://ClinicalTrials.gov/show/NCT02523937 Completed Diagnostica Stago R&D 2018-05-31
NCT02507180 Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer https://ClinicalTrials.gov/show/NCT02507180 Recruiting Ottawa Hospital Research Institute 2021-09-30
NCT02480790 Venous Thromboembolic Complications in Ovarian Cancer https://ClinicalTrials.gov/show/NCT02480790 Active, not recruiting Aalborg University Hospital 2017-05-31
NCT02468102 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden) https://ClinicalTrials.gov/show/NCT02468102 Active, not recruiting Bayer 2018-12-31
NCT02369263 DVT Ultrasound in the Emergency Department https://ClinicalTrials.gov/show/NCT02369263 Completed Emergency Medicine Physicians, Nevada 2014-07-31
NCT02361294 Immature Plateletes in the Etiopathology of Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT02361294 Completed Technische Universität München 2017-04-07
NCT02345356 A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics https://ClinicalTrials.gov/show/NCT02345356 Active, not recruiting University of Puerto Rico 2020-07-31
NCT02345343 Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico https://ClinicalTrials.gov/show/NCT02345343 Completed Bristol-Myers Squibb 2015-10-07
NCT02341937 D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs https://ClinicalTrials.gov/show/NCT02341937 Recruiting G. d’Annunzio University 2020-10-31
NCT02335580 Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02335580 Recruiting General Hospital of Shenyang Military Region 2020-12-31
NCT02297373 Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) https://ClinicalTrials.gov/show/NCT02297373 Active, not recruiting Ottawa Hospital Research Institute 2019-01-03
NCT02268630 Long Term Outcomes of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02268630 Recruiting Ostfold Hospital Trust 2023-10-31
NCT02258958 Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection https://ClinicalTrials.gov/show/NCT02258958 Completed McMaster University 2014-12-31
NCT04452422 Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology https://ClinicalTrials.gov/show/NCT04452422 Recruiting University Hospital, Strasbourg, France 2020-09-23
NCT02210819 Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy https://ClinicalTrials.gov/show/NCT02210819 Completed Bayer 2016-11-03
NCT02156401 VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE https://ClinicalTrials.gov/show/NCT02156401 Recruiting Johannes Gutenberg University Mainz 2023-07-31
NCT02123550 Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection https://ClinicalTrials.gov/show/NCT02123550 Recruiting Swanson Center 2022-08-31
NCT02114983 General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT02114983 Completed Azienda Sanitaria Locale ASL 6, Livorno 2016-03-31
NCT02113475 Venous Thrombectomy/Thrombolysis Outcome Registry https://ClinicalTrials.gov/show/NCT02113475 Recruiting Heart and Vascular Outcomes Research Institute 2020-03-31
NCT02108041 Personalized Medicine Decision-Making in a Virtual Clinical Setting https://ClinicalTrials.gov/show/NCT02108041 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02097602 Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery https://ClinicalTrials.gov/show/NCT02097602 Completed Technische Universität München 2014-09-30
NCT02095925 Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02095925 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2016-06-30
NCT02069457 Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT02069457 Completed Beijing Friendship Hospital 2014-06-30
NCT01318057 Pharmacogenetics of Warfarin in Puerto Ricans. https://ClinicalTrials.gov/show/NCT01318057 Completed University of Puerto Rico 2014-07-31
NCT01297348 Study Of Lybrel In Relation To Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01297348 Completed Pfizer 2012-04-30
NCT01279746 The Diagnosis of Occult Deep Vein Thrombosis of the Lower Extremities in Patients Presenting With Hypoxia https://ClinicalTrials.gov/show/NCT01279746 Completed HaEmek Medical Center, Israel 2011-01-31
NCT02038530 The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study https://ClinicalTrials.gov/show/NCT02038530 Active, not recruiting McMaster University 2020-03-31
NCT02037607 Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures https://ClinicalTrials.gov/show/NCT02037607 Completed Indiana University 2015-07-31
NCT02013635 Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological Correlations https://ClinicalTrials.gov/show/NCT02013635 Completed University Hospital, Rouen 2016-09-30
NCT01947998 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK) https://ClinicalTrials.gov/show/NCT01947998 Completed Bayer 2018-12-31
NCT01947985 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands) https://ClinicalTrials.gov/show/NCT01947985 Completed Bayer 2018-12-31
NCT01855100 Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) https://ClinicalTrials.gov/show/NCT01855100 Completed Bayer 2014-11-30
NCT01805544 Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication https://ClinicalTrials.gov/show/NCT01805544 Completed Bayer 2015-04-30
NCT01736826 Free DNA and Nucleosome Concentrations in Pathological Pregnancies https://ClinicalTrials.gov/show/NCT01736826 Completed Centre Hospitalier Universitaire de Nīmes 2018-12-17
NCT01691495 ARIXTRA® Adherence in SVT Patients. https://ClinicalTrials.gov/show/NCT01691495 Completed GlaxoSmithKline 2014-08-31
NCT01619007 Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy https://ClinicalTrials.gov/show/NCT01619007 Completed Bayer 2015-03-31
NCT01615705 Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial https://ClinicalTrials.gov/show/NCT01615705 Completed Sir Mortimer B. Davis - Jewish General Hospital 2010-09-30
NCT01602445 Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01602445 Completed Ottawa Hospital Research Institute 2016-10-31
NCT01602432 Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients https://ClinicalTrials.gov/show/NCT01602432 Completed Ottawa Hospital Research Institute 2013-08-31
NCT01559883 Study on Thrombosis Therapy in German Cancer Patients https://ClinicalTrials.gov/show/NCT01559883 Completed LEO Pharma 2013-12-31
NCT01559532 Influence of Tourniquet Use and Surgery Duration on the Incidence of Deep Vein Thrombosis in Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01559532 Completed University of Sao Paulo General Hospital 2011-06-30
NCT01501175 Incidence of Superficial Vein Thrombosis https://ClinicalTrials.gov/show/NCT01501175 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-11-30
NCT01457963 Prevalence of Pulmonary Embolism in ICU https://ClinicalTrials.gov/show/NCT01457963 Completed University Hospital, Grenoble 2011-04-30
NCT01444612 Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery https://ClinicalTrials.gov/show/NCT01444612 Completed GlaxoSmithKline 2010-10-31
NCT04391205 A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care Settings https://ClinicalTrials.gov/show/NCT04391205 Completed Azienda Ospedaliera Città della Salute e della Scienza di Torino 2019-02-28
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617 Completed Hospital Universitari Vall d’Hebron Research Institute 2020-04-25
NCT04338932 COVID-19 and Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04338932 Completed Jessa Hospital 2020-05-15
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc) https://ClinicalTrials.gov/show/NCT04335162 Recruiting Centre Hospitalier Universitaire de Nice 2020-08-28
NCT04330170 Inferior Vena Cava Filters: Analysis of a Database https://ClinicalTrials.gov/show/NCT04330170 Completed Pirogov Russian National Research Medical University 2020-03-28
NCT04252651 Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients https://ClinicalTrials.gov/show/NCT04252651 Recruiting Joseph M. Still Research Foundation, Inc. 2020-10-31
NCT03937947 Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study https://ClinicalTrials.gov/show/NCT03937947 Recruiting NHS Lothian 2020-10-31
NCT03909399 Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients https://ClinicalTrials.gov/show/NCT03909399 Recruiting Hellenic Society of Medical Oncology 2020-01-25
NCT03901872 Contemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT03901872 Recruiting Guy’s and St Thomas’ NHS Foundation Trust 2023-02-28
NCT03894878 Association Between Genetic Variant Scores and Warfarin Effect https://ClinicalTrials.gov/show/NCT03894878 Recruiting Cipherome, Inc. 2021-03-12
NCT03877770 DVT After Cardiac Procedure https://ClinicalTrials.gov/show/NCT03877770 Completed Manchester University NHS Foundation Trust 2019-07-31
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study https://ClinicalTrials.gov/show/NCT03835780 Completed Momentum Data 2019-08-01
NCT03784937 Revaluation of Wells’ Clinical Prediction Score of Deep Vein Thrombosis (DVT) in Inpatients With Thromboprophylaxis Treatment https://ClinicalTrials.gov/show/NCT03784937 Completed Centre Hospitalier Universitaire de NÄ«mes 2019-02-01
NCT03707665 Deep Venous Thrombosis Screening in the ICU by Nurses https://ClinicalTrials.gov/show/NCT03707665 Completed Emergency Medical Service of the Central Bohemian Region, Czech Republic 2019-04-30
NCT03650127 Returning Genome and Metabolome Data to FinTerveys 2017 Participants: P5.fi FinTerveys Study https://ClinicalTrials.gov/show/NCT03650127 Enrolling by invitation National Institute for Health and Welfare, Finland 2027-12-31
NCT03611894 Comparison of the Radiological Pattern Between the Cerebral Stroke of Arterial and Venous Origin https://ClinicalTrials.gov/show/NCT03611894 Completed Centre Hospitalier Universitaire, Amiens 2017-07-01
NCT03504007 Registry of Patients Prescribed Anticoagulation https://ClinicalTrials.gov/show/NCT03504007 Recruiting Mayo Clinic 2023-03-01
NCT03477968 ThRombosis ExclUsion STudy https://ClinicalTrials.gov/show/NCT03477968 Recruiting Diagnostica Stago 2020-09-30
NCT01221805 STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01221805 Completed Diagnostica Stago 2016-03-31
NCT01140386 Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients https://ClinicalTrials.gov/show/NCT01140386 Completed Penn State University 2010-03-31
NCT01086215 Registry of AngioJet Use in the Peripheral Vascular System https://ClinicalTrials.gov/show/NCT01086215 Completed Boston Scientific Corporation 2013-07-31
NCT01064362 Hemorrhage Risk Prescribed Arixtra https://ClinicalTrials.gov/show/NCT01064362 Completed GlaxoSmithKline 2010-06-30
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity https://ClinicalTrials.gov/show/NCT01037270 Completed Biosite 2010-04-30
NCT01007045 Limited Compression Ultrasound by Emergency Physicians to Exclude Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT01007045 Completed Queen’s University 2010-12-31
NCT00924859 The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT) https://ClinicalTrials.gov/show/NCT00924859 Completed University Hospital Inselspital, Berne 2017-12-31
NCT00905177 Predictors of Anticoagulation Control on Warfarin Therapy https://ClinicalTrials.gov/show/NCT00905177 Completed University of Pennsylvania 2013-08-31
NCT00867646 Comparison Study of CoaguChek XS PT and Laboratory Innovin PT by NTUH Lab Medicine https://ClinicalTrials.gov/show/NCT00867646 Completed National Taiwan University Hospital 2008-08-31
NCT04400877 Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400877 Recruiting University Hospital, Linkoeping 2020-06-19
NCT03889457 What Treatment for Patients With Phlebitis or Pulmonary Embolism ? https://ClinicalTrials.gov/show/NCT03889457 Recruiting Rennes University Hospital 2021-02-12
NCT03773939 Risk Prediction of Venous Thromboembolism in Critically Ill https://ClinicalTrials.gov/show/NCT03773939 Recruiting University Medical Center Groningen 2021-05-01
NCT01947959 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany) https://ClinicalTrials.gov/show/NCT01947959 Completed Bayer 2018-12-31
NCT01721928 Norwegian Intensive Care Unit Dalteparin Effect Study https://ClinicalTrials.gov/show/NCT01721928 Completed Oslo University Hospital 2016-06-02
NCT01470547 Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry https://ClinicalTrials.gov/show/NCT01470547 Completed University of Roma La Sapienza 2017-04-30
NCT03114618 A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient https://ClinicalTrials.gov/show/NCT03114618 Completed Hospital General Universitario Gregorio Marañon 2016-11-30
NCT02502396 Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center https://ClinicalTrials.gov/show/NCT02502396 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT01857050 Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins https://ClinicalTrials.gov/show/NCT01857050 Completed Meir Medical Center 2014-01-31
NCT00816920 Natural History of Isolated Deep Vein Thrombosis of the Calf https://ClinicalTrials.gov/show/NCT00816920 Completed St. Orsola Hospital 2009-09-30
NCT00778336 A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters https://ClinicalTrials.gov/show/NCT00778336 Completed Boston Scientific Corporation 2010-03-31
NCT00771303 Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study https://ClinicalTrials.gov/show/NCT00771303 Completed University Hospital, Geneva 2017-08-31
NCT00740454 Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and Postpartum https://ClinicalTrials.gov/show/NCT00740454 Completed University Hospital, Brest 2009-04-30
NCT00713973 Comparative Study Between Thrombosis Prophylaxis Protocols https://ClinicalTrials.gov/show/NCT00713973 Completed UPECLIN HC FM Botucatu Unesp NA
NCT00660205 Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00660205 Completed University of Aarhus 2011-02-28
NCT00550082 3 Screen Electronic Alert https://ClinicalTrials.gov/show/NCT00550082 Completed Brigham and Women’s Hospital 2009-11-30
NCT00549705 Registry of Hospitalized Patients Treated With Fondaparinux https://ClinicalTrials.gov/show/NCT00549705 Completed Brigham and Women’s Hospital 2009-06-30
NCT00535171 Venous Thromboembolism Taskforce Audit Program https://ClinicalTrials.gov/show/NCT00535171 Completed Sanofi 2008-08-31
NCT00480636 Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients https://ClinicalTrials.gov/show/NCT00480636 Completed Pfizer 2009-06-30
NCT00456196 Epidemiology of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00456196 Completed Brigham and Women’s Hospital 2009-06-30
NCT00409136 Multi-Center Human Alert Trial to Prevent DVT and PE https://ClinicalTrials.gov/show/NCT00409136 Completed Brigham and Women’s Hospital 2008-08-31
NCT00395265 Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome https://ClinicalTrials.gov/show/NCT00395265 Completed University of Vermont 2011-12-31
NCT00336258 US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status https://ClinicalTrials.gov/show/NCT00336258 Completed Rambam Health Care Campus 2010-12-31
NCT00285038 Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer Patients https://ClinicalTrials.gov/show/NCT00285038 Completed Rambam Health Care Campus 2010-12-31
NCT00266045 D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence https://ClinicalTrials.gov/show/NCT00266045 Completed St. Orsola Hospital 2008-06-30
NCT00178789 Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT00178789 Completed The University of Texas Health Science Center, Houston NA
NCT00795743 Coagulation Changes in Trauma Patients https://ClinicalTrials.gov/show/NCT00795743 Completed University of Miami 2012-06-30
NCT00018772 Risk Factors for Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00018772 Completed VA Office of Research and Development NA
NCT00005684 Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis https://ClinicalTrials.gov/show/NCT00005684 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005504 Epidemiology of Venous Thrombosis and Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00005504 Active, not recruiting University of Minnesota 2030-04-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03148548 Substudy - Evaluation of Patients With Iliac Vein Thrombosis https://ClinicalTrials.gov/show/NCT03148548 Completed Cardioangiologisches Centrum Bethanien 2018-01-31
NCT03089255 Assessment of the Impact of TIP Score on Thromboprophylaxis in Patients With Non-surgical Lower Leg Trauma. https://ClinicalTrials.gov/show/NCT03089255 Completed University Hospital, Angers 2018-01-15
NCT02875899 Surfacer System to Facilitate Access in Venous Occlusions https://ClinicalTrials.gov/show/NCT02875899 Completed Bluegrass Vascular Technologies 2018-09-20
NCT02697123 Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients https://ClinicalTrials.gov/show/NCT02697123 Active, not recruiting Baylor College of Medicine 2020-01-31
NCT03388775 Real World Study of Deep Venous Thrombosis. Analysis of Prospective Cases in University Hospitals of São Paulo https://ClinicalTrials.gov/show/NCT03388775 Recruiting Fundação Faculdade Regional de Medicina de São José do Rio Preto 2020-12-31
NCT02532387 Outpatient Treatment of PE and DVT in the Emergency Department https://ClinicalTrials.gov/show/NCT02532387 Completed Massachusetts General Hospital 2017-02-28
NCT02489721 Major Complications Related to PICC and Midline Insertion https://ClinicalTrials.gov/show/NCT02489721 Completed Azienda Ospedaliera S. Maria della Misericordia 2020-01-31
NCT02155491 Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events https://ClinicalTrials.gov/show/NCT02155491 Active, not recruiting Thrombosis Research Institute 2020-01-04
NCT02032030 Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys https://ClinicalTrials.gov/show/NCT02032030 Active, not recruiting Washington University School of Medicine 2020-07-31
NCT01871194 An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®). https://ClinicalTrials.gov/show/NCT01871194 Completed Drug Safety Research Unit, Southampton, UK 2016-01-31
NCT04414332 Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry https://ClinicalTrials.gov/show/NCT04414332 Completed University of California, Los Angeles 2020-02-27
NCT04370691 JET Enhanced Thrombectomy Intervention https://ClinicalTrials.gov/show/NCT04370691 Enrolling by invitation Walk Vascular LLC 2022-03-31
NCT04124159 Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism https://ClinicalTrials.gov/show/NCT04124159 Recruiting Medical University of Vienna 2023-12-31
NCT03881345 Ongoing Registry of Treatment of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03881345 Recruiting Medalp Private Surgery Clinic 2036-03-01
NCT03778502 DOAC in Unusual Site Venous Thrombosis https://ClinicalTrials.gov/show/NCT03778502 Recruiting University of Malta 2022-12-31
NCT03714048 Blood Management During ECMO for Cardiac Support https://ClinicalTrials.gov/show/NCT03714048 Recruiting St Vincent’s Hospital, Sydney 2021-07-31
NCT03575364 ClotTriever Outcomes (CLOUT) Registry https://ClinicalTrials.gov/show/NCT03575364 Enrolling by invitation Inari Medical 2020-06-01